Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

August 10, 2018

Conditions
Self-Injurious BehaviorSuicidal IdeationSuicide, AttemptedBorderline Personality DisorderEmergency Services, Psychiatric
Interventions
OTHER

Brief Admission

Participants randomised to Brief admission (BA) will participate in a negotiation together with their out-patient clinician and a representative from the ward. The aim of the negotiation is to form an individualised contract defining how BA will work for them. After signing the contract, will have the possibility to admit themselves to hospital according to the procedure stated in the contract.

Trial Locations (1)

22185

Division of Psychiatry, Region Skåne, Lund

All Listed Sponsors
collaborator

Lund University

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

Region Skane

OTHER

NCT02985047 - Brief Admission Skane: Replacing General Admission for Individuals With Self-harm and Acute Risk of Suicide | Biotech Hunter | Biotech Hunter